학술논문
Nivolumab (NIVO) and ipilimumab (IPI) treatment in prostate cancer with an immunogenic signature: cohort 1 of the NEPTUNES multi-centre, two-stage biomarker-selected Phase II trial.
Document Type
Journal
Author
Linch, Mark D.; Wong, Yien Ning Sophia; Jones, Robert; Sankey, Peter; Josephs, Debra H.; Crabb, Simon J.; Staffurth, John; Zarkar, Anjali; White, Laura; Duggan, Marian; Pellizzari, Giulia; Wheeler, Graham; Beare, Sandy; Cartwright, Hayley; Linares, Josep; Akarca, Ayse; Quezada, Sergio A.; Ensell, Leah; Hartley, John; Attard, Gerhardt; Burr, Joanna; Jayaram, Anuradha; Kularatne, Bihani; Kayani, Mahaz; Chung, Moon; Pritchard, Colin C.; Freeman, Alex; Haider, Aiman; Marafioti, Teresa
Source
Subject
Language
English
ISSN
15387445